ARTICLE | Clinical News
VerifyNow P2Y12 assay regulatory update
May 23, 2011 7:00 AM UTC
Accumetrics received CE Mark approval in the EU for its VerifyNow P2Y12 assay to identify patients with high residual platelet reactivity on antiplatelet therapy at risk for cardiovascular events. The...